Clinical Trials in Porto Alegre, Brazil
Locations / Porto Alegre, Brazil
Delta Trials records 3,248 clinical trials conducted in Porto Alegre, Brazil, making it a notable site of clinical research activity. These trials across 2,150 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 287 trials in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Porto Alegre has changed over time.
3248
Total Trials
2150
Conditions
287
Terminated since 2020
Browse by condition (2150 total)
- Breast cancer 100 trialsAll Breast cancer trials
- Diabetes mellitus, type 2 75 trialsAll Diabetes mellitus, type 2 trials
- Non-small cell lung cancer 70 trialsAll Non-small cell lung cancer trials
- Asthma 55 trialsAll Asthma trials
- Hypertension 48 trialsAll Hypertension trials
- COVID-19 40 trialsAll COVID-19 trials
- Heart failure 38 trialsAll Heart failure trials
- Carcinoma, non-small-cell lung 37 trialsAll Carcinoma, non-small-cell lung trials
- Rheumatoid arthritis 36 trialsAll Rheumatoid arthritis trials
- Prostate cancer 36 trialsAll Prostate cancer trials
- Obesity 34 trialsAll Obesity trials
- Systemic lupus erythematosus 32 trialsAll Systemic lupus erythematosus trials
- Multiple myeloma 31 trialsAll Multiple myeloma trials
- Melanoma 28 trialsAll Melanoma trials
- Pulmonary arterial hypertension 25 trialsAll Pulmonary arterial hypertension trials
- Cardiovascular diseases 25 trialsAll Cardiovascular diseases trials
- Crohn's disease 25 trialsAll Crohn's disease trials
- Diabetes 24 trialsAll Diabetes trials
- Stroke 24 trialsAll Stroke trials
- Coronary artery disease 23 trialsAll Coronary artery disease trials